Mexico launches first approved DENGUE Vaccine

Published On 2015-12-10 07:34 GMT   |   Update On 2015-12-10 07:34 GMT

Mexico City: Mexico unveiled the world`s first approved dengue vaccine, saying the treatment is 60.5 percent effective against dengue and 93.2 percent effective against severe dengue.The approval followed two years of clinical trials worldwide on more than 40,000 patients, including Mexicans, the health ministry said in a statement on Wednesday."This vaccine can prevent more than...

Login or Register to read the full article
Mexico City: Mexico unveiled the world`s first approved dengue vaccine, saying the treatment is 60.5 percent effective against dengue and 93.2 percent effective against severe dengue.

The approval followed two years of clinical trials worldwide on more than 40,000 patients, including Mexicans, the health ministry said in a statement on Wednesday.

"This vaccine can prevent more than 8,000 hospitalisations, 104 deaths annually, and save 1.1 billion pesos ($64 million) each year in reduced costs tied to medical attention," the statement said.

According to the World Health Organisation (WHO), "nearly 40 percent of the world`s population (3.9 billion people) is at risk of contracting dengue."

Around 400 million people in more than 128 countries are infected with the mosquito-borne virus each year.

In Mexico, a total of 32,100 cases were registered last year, including 8,668 cases of severe dengue, which cost the country over 3.2 billion pesos ($187 million).
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News